Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 600566, Taiwan.
Department of Applied Life Science and Health, Chia-Nan University of Pharmacy and Science, Tainan 717301, Taiwan.
Int J Mol Sci. 2021 Nov 1;22(21):11857. doi: 10.3390/ijms222111857.
Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease and end-stage renal disease. The natural history of DKD includes glomerular hyperfiltration, progressive albuminuria, declining estimated glomerular filtration rate, and, ultimately, kidney failure. It is known that DKD is associated with metabolic changes caused by hyperglycemia, resulting in glomerular hypertrophy, glomerulosclerosis, and tubulointerstitial inflammation and fibrosis. Hyperglycemia is also known to cause programmed epigenetic modification. However, the detailed mechanisms involved in the onset and progression of DKD remain elusive. In this review, we discuss recent advances regarding the pathogenic mechanisms involved in DKD.
糖尿病肾病(DKD)是导致慢性肾脏病和终末期肾病的主要原因。DKD 的自然病程包括肾小球高滤过、进行性白蛋白尿、估算肾小球滤过率下降,最终导致肾衰竭。已知 DKD 与高血糖引起的代谢变化有关,导致肾小球肥大、肾小球硬化以及小管间质炎症和纤维化。高血糖还会导致程序性表观遗传修饰。然而,DKD 发病和进展中涉及的详细机制仍不清楚。在这篇综述中,我们讨论了 DKD 发病机制的最新研究进展。